SMFL · Smart for Life, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.27M | $877.8K | $478.9K | - | $2.75M | $2.28M | $2.40M | - | $3.37M | $4.29M |
| Cost of Revenue | $751.3K | $471.7K | $271.2K | - | $1.69M | $1.54M | $1.58M | - | $2.72M | $846.2K |
| Gross Profit | $518.1K | $406.1K | $207.7K | - | $1.06M | $742.0K | $827.7K | - | $1.44M | $1.78M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $428.6K | $263.4K | $642.3K | - | $1.24M | $1.50M | $1.10M | - | $910.0K | $3.96M |
| Total Operating Expenses | $1.72M | $1.44M | $2.20M | - | $4.27M | $4.80M | $3.59M | - | $3.20M | $4.39M |
| D&A | $45.6K | - | $323.1K | - | $615.8K | $507.6K | $81.0K | - | $522.4K | $20.7K |
| Operating Income | ($1.20M) | ($1.04M) | ($1.99M) | - | ($3.21M) | ($4.06M) | ($2.76M) | - | ($1.45M) | ($905.8K) |
| Interest Expense | $2.05M | $1.08M | $987.3K | - | $426.6K | - | $1.45M | - | - | - |
| Income Tax | - | - | - | - | ($16.0K) | ($135.0K) | - | - | - | - |
| Net Income | ($3.24M) | ($2.21M) | ($2.90M) | - | ($4.34M) | ($4.22M) | ($4.28M) | - | ($1.95M) | ($3.39M) |
| EPS - Basic | ($0.94) | ($2.48) | ($11.13) | - | ($52.57) | ($122.64) | ($342.09) | - | ($220.50) | ($346.50) |
| EPS - Diluted | ($0.94) | ($2.48) | ($11.13) | - | ($52.57) | ($122.64) | ($342.09) | - | ($220.50) | ($346.50) |
Balance Sheet
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.7K | $31.7K | $21.3K | $188.6K | $8.9K | $375.7K | $86.2K | $69.7K | $303.5K | $107.3K |
| Accounts Receivable | $98.0K | $76.8K | $76.8K | $70.2K | $412.5K | $521.8K | $278.7K | $561.9K | $754.9K | $890.4K |
| Inventory | $747.2K | $964.4K | $1.19M | $1.24M | $1.99M | $1.89M | $2.10M | $2.67M | $5.60M | $4.94M |
| Accounts Payable | $3.62M | $4.03M | $4.57M | $3.61M | $4.24M | $3.71M | $4.81M | $4.12M | $3.44M | $2.95M |
| Current Assets | $1.66M | $1.88M | $1.85M | $2.33M | $2.55M | $3.15M | $2.78M | $3.60M | $8.32M | $8.41M |
| Total Assets | $12.73M | $13.29M | $13.64M | $19.66M | $25.54M | $27.01M | $27.55M | $29.15M | $34.15M | $26.22M |
| Current Liabilities | $9.85M | $11.60M | $12.87M | $22.06M | $13.92M | $12.77M | $18.01M | $15.14M | $16.82M | $11.51M |
| Long-term Debt | $3.24M | $5.32M | $7.08M | $12.36M | $12.91M | $12.58M | $21.67M | $21.70M | $23.05M | $12.74M |
| Total Liabilities | $11.79M | $14.60M | $16.97M | $26.05M | $24.59M | $22.45M | $34.15M | $31.51M | $32.10M | $22.22M |
| Stockholders' Equity | $938.5K | ($1.30M) | ($3.33M) | ($6.39M) | $951.8K | $4.56M | ($6.59M) | ($2.36M) | $2.05M | $4.00M |
| Retained Earnings | ($76.01M) | ($72.78M) | ($70.56M) | ($67.67M) | ($57.84M) | ($53.50M) | ($49.28M) | ($44.99M) | ($36.92M) | ($34.97M) |
Cash Flow
| Line item | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($540.1K) | - | - | - | ($378.7K) | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | $406.8K | - | - | - | $395.2K | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 40.8% | 46.3% | 43.4% | - | 38.6% | 32.5% | 34.4% | - | 42.6% | 41.6% |
| Operating margin | -94.9% | -118.1% | -415.9% | - | -116.6% | -177.8% | -114.9% | - | -42.9% | -21.1% |
| EBITDA margin | -91.3% | - | -348.5% | - | -94.2% | -155.5% | -111.5% | - | -27.4% | -20.7% |
| Net margin | -254.9% | -251.9% | -604.7% | - | -158.0% | -184.8% | -178.2% | - | -57.8% | -79.0% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 33.8% | 30.0% | 134.1% | - | 45.0% | 65.9% | 45.5% | - | 27.0% | 92.4% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -25.4% | -16.6% | -21.2% | - | -17.0% | -15.6% | -15.5% | - | -5.7% | -12.9% |
| Return on equity | -344.8% | 169.8% | 87.0% | - | -456.4% | -92.5% | 65.0% | - | -95.0% | -84.7% |
| Return on invested capital | - | - | - | - | -18.3% | -18.7% | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.17 | 0.16 | 0.14 | 0.11 | 0.18 | 0.25 | 0.15 | 0.24 | 0.49 | 0.73 |
| Quick ratio | 0.09 | 0.08 | 0.05 | 0.05 | 0.04 | 0.10 | 0.04 | 0.06 | 0.16 | 0.30 |
| Cash ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | 0.02 | 0.01 |
| Leverage | ||||||||||
| Debt / Equity | 3.45 | -4.09 | -2.12 | -1.94 | 13.56 | 2.76 | -3.29 | -9.19 | 11.24 | 3.18 |
| Debt / Assets | 0.25 | 0.40 | 0.52 | 0.63 | 0.51 | 0.47 | 0.79 | 0.74 | 0.68 | 0.49 |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -0.6x | -1.0x | -2.0x | - | -7.5x | - | -1.9x | - | - | - |
| Equity multiplier | 13.56 | -10.21 | -4.10 | -3.08 | 26.83 | 5.92 | -4.18 | -12.34 | 16.65 | 6.56 |
| Liabilities / Assets | 0.93 | 1.10 | 1.24 | 1.32 | 0.96 | 0.83 | 1.24 | 1.08 | 0.94 | 0.85 |
| Efficiency | ||||||||||
| Asset turnover | 0.10 | 0.07 | 0.04 | - | 0.11 | 0.08 | 0.09 | - | 0.10 | 0.16 |
| Inventory turnover | 1.01 | 0.49 | 0.23 | - | 0.85 | 0.81 | 0.75 | - | 0.49 | 0.17 |
| Days sales outstanding | 28d | 32d | 59d | - | 55d | 83d | 42d | - | 82d | 76d |
| Days inventory outstanding | 363d | 746d | 1598d | - | 430d | 448d | 485d | - | 750d | 2131d |
| Days payable outstanding | 1761d | 3119d | 6145d | - | 917d | 879d | 1113d | - | 461d | 1272d |
| Cash conversion cycle | -1370d | -2341d | -4488d | - | -433d | -347d | -586d | - | 371d | 935d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | 0.2x | - | - | - | 10.5x | 7.7x | - | - | 16391.4x | 5821.4x |
| P / S | 0.1x | 3.0x | - | - | 3.6x | 15.3x | - | - | 9983.6x | 5432.2x |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -53.8% | -61.6% | -80.1% | - | -18.3% | -46.7% | -46.0% | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -51.2% | -45.3% | -74.9% | - | -26.1% | -58.3% | -45.5% | - | - | - |
| Operating income growth (YoY) | 62.5% | 74.5% | 27.9% | - | -121.7% | -348.2% | 15.6% | - | - | - |
| Net income growth (YoY) | 25.5% | 47.6% | 32.4% | - | -123.0% | -24.7% | 74.2% | - | - | - |
| EPS growth (YoY) | 98.2% | 98.0% | 96.7% | - | 76.2% | 64.6% | -41618.3% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -1.4% | - | 49.5% | -170.4% | -53.6% | 14.0% | -8.3% | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Product / service
$16.09M totalProduct$7.86M · 48.9%
Retail$6.88M · 42.8%
Contarct Manufacturing$983.3K · 6.1%
Advertising$361.8K · 2.2%
Peer comparison
Same SIC group: Medicinal Chemicals & Botanical Products
Comparing SMART FOR LIFE against the 5 most active filers in the same SIC group.